http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018225063-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc57517f4e241a6fd0d6acc851fc37f1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
filingDate 2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ee56aaadf7d9a14e684565794fa534
publicationDate 2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018225063-A1
titleOfInvention Method of predicting personalized response to cancer treatment with immune checkpoint inhibitors and kits therefor
abstract A method and a kit are provided for predicting a favorable or a non-favorable response of a cancer patient to treatment with an immune checkpoint inhibitor by determining in a biological sample obtained from the cancer patient, before and after the treatment, the changes of the levels of factors/biomarkers generated by the cancer patient in response to said treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020121315-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022011616-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020121310-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019229752-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021229032-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022011313-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220156855-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021193802-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020124083-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020247521-A1
priorityDate 2017-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016156501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017040960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017140826-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018071824-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID229455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163

Total number of triples: 64.